Tagung 14.–17. Oktober 1987, Stuttgart pp 571-591 | Cite as
Nierentransplantation
Conference paper
Zusammenfassung
Feinnadelaspirationszytologien (FNAC) sind immer kontaminiert mit Leukozyten sowie Zellen des Nierenmarkes. Dieses kann eine falsche Interpretation hervorrufen, da die zelluläre Rejektion bei Nierentransplantaten im Bereich der Nierenrinde und des corticomedullären Überganges beginnt [1]. Ziel unserer Untersuchung war es, zytologische Kriterien für die Unterscheidung zwischen Nierencortex und Nierenmedulla zu finden:
-
in-vitro bei tumornephrektomierten Nieren und explantierten Nierentransplantaten
-
in-vivo mit der selektiven Aspirationszytologie des Nierencortex und der Nierenmedulla bei Transplantatnieren in der rountinemäßigen postoperativen Nachsorge.
Preview
Unable to display preview. Download preview PDF.
Literatur
- 1.Zollinger HU, Mihatsch MJ (1978) Renal Pathology in Biopsy. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
- 2.Häyry P, Von Villebrand E (1981) Monitoring of human renal allograft rejection with fine needle aspiration cytology. Scan J Immunol 13: 87CrossRefGoogle Scholar
- 3.Nguyen L, Hammer C, Dendorfer U, Castro L, Schleibner C, Land W (1985) Changes in large granular lymphoicyte size and number in kidney transplant patients during rejection and viral infection. Tansplant Proc 17: 2110Google Scholar
- 4.Lopez Blanco OA, Cavalli NH, Verruno L, Iotti R, Boullon F, Nadal MA, Favaloro R, Gotlieb D (1987) Correlation between histopathology and aspiration cytology of kidney grafts in 43 cases. Transplant Proc 19: 1655PubMedGoogle Scholar
- 5.Van Oers MHJ, Surancho S, Wilmink JM (1987) Infiltrate analysis by monoclonal antibodies does not contribute to the usefulness of fine needle aspiration biopsy. Transplant Proc 19: 1646PubMedGoogle Scholar
- 6.Gupta R, Om A, Ghose T, Belitsky P (1987) Distinction between cortex and medulla in kidney transplant aspiration cytology and relevance to interpretation of results. Transplant Proc 19: 1641PubMedGoogle Scholar
- 7.Von Villebrand E, Häyry P (1984) Reproducibility of the fine-needle aspiration biopsy. Transplantation 38: 314CrossRefGoogle Scholar
- 1.Brigati DJ et al (1983) Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridisation probes. Virology 126: 32–40PubMedCrossRefGoogle Scholar
- 2.Hammerer P, Arndt R, Milde K, Loening Th, Huland H (1987) Analysis of T-cell cubsets and DNA in-situ-hybridization. A new diagnostic tool for virus infections in kidney transplants. Invest Urology 2: 241–246Google Scholar
- 3.Glenn J (1981) Cytomegalovirus infections following renal transplantation. Rev Inf Dis 3: 1151–1178CrossRefGoogle Scholar
- 4.Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE (1981) Infection in the renal transplant recipient. Am J Med 70: 405–411PubMedCrossRefGoogle Scholar
- 1.Eigler I, Land W (1985) Notwendigkeit und Wert von Untersuchungen zur Vorbereitung der Nierentransplantation. Mitt Klin Nephrol XIV: 15–25Google Scholar
- 2.Franke H (1984) Wesen und Bedeutung der Polypathie und Multimorbidität in der Altersheilkunde. Internist 25: 451–455PubMedGoogle Scholar
- 3.Frei U (1985) Risikofaktoren bei Nierentransplantat-Empfängern–Notwendigkeit von Vorsorgeuntersuchungen. Dialyse J 12: 14–18Google Scholar
- 4.Hoynestadt J, Flatmark A (1976) Colonperforation in renal transplant patients. Scand J Gastroenterol 11: 289–292Google Scholar
- 5.Livio M, Benigni A, Vigano G, Mecca G, Remuzzi G (1986) Moderate dosis of aspirin and risk of bleeding in renal failure. Lancet I: 414–416CrossRefGoogle Scholar
- 6.Malkowicz SB, Perloff LJ (1985) Urologycal considerations in renal transplantation. Surg Gynecol Obstet 160: 579–588PubMedGoogle Scholar
- 7.Neuhaus P, Frei U, Ringe B, Pichlmayr R (1985) Was soll chirurgischerweise vor einer Nierentransplantation behandelt und operiert werden? Mitt Klin Nephrol XIV: 26–31Google Scholar
- 8.Opelz G (1986) Collaborative transplant study. Newslett 2–7Google Scholar
- 9.Pichlmayr R, Neuhaus P (1981) Voruntersuchung und Vorbehandlung des (potentiellen) Transplantatempfängers. In: Pichlmayr R (Hrsg) Transplantationschirurgie. Springer, Berlin Heidelberg New York, S 383–416CrossRefGoogle Scholar
- 10.Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS (1971) Renal transplantation in high risk patients. Arch Surg 103: 290–298PubMedCrossRefGoogle Scholar
- 11.Tilney NL, Strom TB, Vineyard GC, Merill JP (1978) Factors contributing to the declining mortality rate in renal transplantation. N Engl J Mat 229: 1321–1325CrossRefGoogle Scholar
- 1.Bakshandeh K, Lynne C, Carrion H (1976) Vesicoureteral reflux and end stage renal disease. J Urol 116: 557–558PubMedGoogle Scholar
- 2.Dreikorn K, Palmtag H, Röhl L, Horsch R (1978) Urologische Diagnostik und Therapie bei potentiellen Transplantatempfängern. Therapiewoche 28: 2210–2216Google Scholar
- 3.Huland H, Buchardt P, Köllermann M, Augustin J (1979) Vesicoureteral reflux in endstage renal disease. J Urol 121: 10–12PubMedGoogle Scholar
- 4.Mosconi CEV, Ianhez LE, Borrelli M, Sabbaga E, Campos Freire JG (1975) Vesicoureteral reflux in patients in end-stage chronic renal failure. Urol Int 30: 357–361PubMedCrossRefGoogle Scholar
- 5.Pichlmayr R, Neuhaus P (1981) Vorbehandlung des Transplantatempfängers. In: Pichlmayr R (Hrsg) Transplantationschirurgie. Springer, Berlin Heidelberg New York, S 408–418Google Scholar
- 6.Salvatierry O, Tanagho EA (1977) Reflux as a cause of end stage kidney disease: report of 32 cases. J Urol 117: 441–443Google Scholar
- 1.Rohowsky-Kochan C, Reed E, Suciu-Foca N, Kung P, Reemtsma K, King DW (1983) Inhibition of MLC reactivity to autologous alloactivated T lymphoblasts by sera from renal allograft recipients. Transplant Proc 15: 1761–1763Google Scholar
- 2.Batchelor JR, Phillips BE, Grennan D (1984) Suppressor cells and their role in the survival of immunologically enhanced rat kidney allografts. Transplantation 37: 43–46PubMedCrossRefGoogle Scholar
- 1.Barnes BA (1965) Transplantation 3: 812–814PubMedCrossRefGoogle Scholar
- 2.Blohme I, Berglin E, Brynger H (1982) Transplant Proc XIV 1, 72/73Google Scholar
- 3.Brown WW, Davis BB et al (1986) Arch Int Med 146 (9): 1790–1796CrossRefGoogle Scholar
- 4.Ploeg RJ, Visser MJT et al (1987) Transplant Proc 19, 1, 1532–1534PubMedGoogle Scholar
- 5.Van der Vliet JA, Persijn GG et al (1981) Scand J Urol Nephrol Suppl 64: 132–136PubMedGoogle Scholar
- 1.Hirsch RL, Layton PC, Barnes LA, Kremer AB, Goldstein G (1987) Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy. Transplant Proc 2, Suppl 1: 32–36Google Scholar
- 2.Monaco A, Goldstein G, Barnes L (1987) Use of orthoclone OKT3 monoclonal antibody to reverse acute renal rejection unresponsive to treatment with conventional immunosuppressive regimens. Transplant Proc 2, Suppl 1: 28–31Google Scholar
- 3.Norman DJ, Shield III CF, Barry J, Henell K, Funnell MB, Lemon J (1987) A US clinical study of orthoclone OKT3 in renal transplantation. Transplant Proc 2, Suppl 1: 21–27Google Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 1988